In agreement with these reports, in individuals with mild hyperglycemia or those who are insulin-naïve or using low doses of outpatient treatment with insulin, the InsulinAPP application recommends an initial approach with bolus-correction regimen ( 16 ). This evidence concerns the gene INS and Hyperglycemia.